A Pediatric Patient with Idiopathic Short Stature Who Developed Obstructive Sleep Apnea after Starting Growth Hormone

Morkous Ss1,2,3

  • 1Department of Pediatrics, Pediatric Neurology Division, Lehigh Valley Children's Hospital, Allentown, PA, USA.

Insights

Growth hormone (GH) therapy may worsen obstructive sleep apnea (OSA) in children. This case study suggests careful sleep monitoring during GH treatment for idiopathic short stature is needed.

Area of Science:

  • Pediatric Endocrinology
  • Sleep Medicine
  • Genetics

Background:

  • Growth hormone (GH) therapy is suspected to induce obstructive sleep apnea (OSA).
  • Concerns exist regarding GH worsening sleep apnea, particularly in Prader-Willi syndrome (PWS).
  • Routine polysomnography (PSG) is recommended for PWS patients before GH, but not established for other pediatric groups.

Purpose of the Study:

  • To highlight the potential link between GH therapy and the development of OSA in pediatric patients.
  • To emphasize the need for vigilance regarding sleep-related side effects of GH treatment.
  • To advocate for further research into PSG guidelines for GH-eligible children.

Main Methods:

  • Case report of a 15-year-old male with headaches and short stature.
  • Initial sleep study showed mild snoring; a follow-up study after GH therapy revealed significantly worsened obstructive sleep apnea.
  • Surgical intervention (tonsillectomy and adenoidectomy) led to symptom resolution.

Main Results:

  • A 15-year-old patient on GH therapy experienced a dramatic increase in his obstructive apnea-hypopnea index.
  • Symptoms of worsening sleep apnea resolved post-tonsillectomy and adenoidectomy.
  • The case underscores a potential complication of GH therapy.

Conclusions:

  • GH therapy may necessitate careful consideration of sleep apnea risks.
  • Further research is needed to establish definitive guidelines for PSG before and during GH therapy in children with idiopathic short stature and initially normal sleep studies.
  • Caution is advised for all patients eligible for GH therapy regarding potential sleep disturbances.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
599
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.2K
Types of Hormones02:13

Types of Hormones

Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
84.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
279
Plant Hormones01:56

Plant Hormones

Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334